{"id":826502,"date":"2025-03-17T16:03:09","date_gmt":"2025-03-17T20:03:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/"},"modified":"2025-03-17T16:03:09","modified_gmt":"2025-03-17T20:03:09","slug":"kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/","title":{"rendered":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call<\/b><\/p>\n<p class=\"bwalignc\"><i>Believes Proposed Transaction with Akoya Significantly Undervalues Quanterix<\/i><\/p>\n<p class=\"bwalignc\"><i>Encourages Shareholders to Vote Against Transaction to Protect Long-Term Value of their Investment<\/i><\/p>\n<p>RINCON, Puerto Rico&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nKent Lake PR LLC (\u201cKent Lake\u201d) is a holder of 7.47% of the outstanding common stock of Quanterix Corporation (\u201cQuanterix\u201d or the \u201cCompany\u201d) (NASDAQ: QTRX). Kent Lake has previously issued a <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkentlake.s3.us-west-1.amazonaws.com%2FQTRX-AKYA_KLPRVoteNoDeck.pdf&amp;esheet=54224976&amp;newsitemid=20250317350313&amp;lan=en-US&amp;anchor=public+presentation&amp;index=1&amp;md5=3d2874e92fe780ca61d1f0c55f02e042\">public presentation<\/a> detailing its opposition to the Company\u2019s proposed transaction (the \u201cTransaction\u201d) with Akoya Biosciences (\u201cAkoya\u201d) (NASDAQ: AKYA), and has also <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20250302423208%2Fen%2FKent-Lake-Nominates-Three-Highly-Qualified-Independent-Candidates-for-Quanterix-Board&amp;esheet=54224976&amp;newsitemid=20250317350313&amp;lan=en-US&amp;anchor=nominated&amp;index=2&amp;md5=ce02c5314a931458300c987ca9fdfcab\">nominated<\/a> three highly qualified, independent candidates for election to the Company\u2019s Board of Directors (the \u201cBoard\u201d).\n<\/p>\n<p><b>Kent Lake urges Quanterix management to address the following questions related to the Transaction on its earnings call today:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b><i>Disproportionate Value Distribution:<\/i><\/b> Why does Quanterix continue to pursue a transaction that allocates over 82% of the combined company enterprise value to Akoya shareholders and less than 18% to Quanterix shareholders?\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b><i>Akoya Going Concern:<\/i><\/b> When evaluating Akoya\u2019s liquidity and going concern issues, as well as its potential impact on Quanterix shareholders&#8217; value, what key findings and assumptions did the Quanterix Board review and rely on to inform their M&amp;A evaluation and approve the terms of this merger, which awards Akoya shareholders a significant valuation premium on all metrics compared to Quanterix shareholders in spite of Akoya\u2019s going concern disclosures?\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b><i>Conflicts of Interest: <\/i><\/b>To what extent was Dr. Ivana Magov\u010devi\u0107-Liebisch allowed to attend meetings, participate in discussions, and vote on matters related to the Akoya merger, despite her conflict of interest as a Board member at Akoya\u2019s key commercial diagnostic partner?\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b><i>Material NIH Risk: <\/i><\/b>Given that uncertainty around National Institutes of Health (\u201cNIH\u201d) funding has led to a significant revaluation across the sector, and this uncertainty is material enough for peer companies to begin including new NIH-related risk factor disclosures in their FY 2024 10-K filings, how can Quanterix shareholders reasonably rely on the forward-looking statements, financial projections, fairness opinions, and purported merger benefits being presented that don\u2019t account for or contemplate this new material risk?\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b><i>Akoya\u2019s Process:<\/i><\/b> Given the S-4 discloses that Quanterix was bidding against itself by the end of the process, and that all other bidders had already walked away without making final offers due to concerning issues such as Akoya\u2019s high cash burn and debt, how is the Quanterix Board integrating this information into their fiduciary framework to continue to recommend the Merger?\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b><i>The Board\u2019s Recommendation: <\/i><\/b>Considering these outstanding issues and insufficient disclosures, what steps does the Quanterix Board plan to take to ensure they are fulfilling their fiduciary duties and are not required to withdraw their Merger recommendation?\n<\/li>\n<\/ul>\n<p><b><i>Kent Lake believes that Quanterix shareholders cannot make a fully informed vote, and the Quanterix Board cannot fulfill its fiduciary duties, if these questions on merger terms, conflicts of interest, unaddressed risks, and unreliable forward-looking statements are left unanswered and the material facts undisclosed.<\/i><\/b><\/p>\n<p><b>About Kent Lake<\/b><\/p>\n<p>\nKent Lake Partners LP is an investment fund founded by Ben Natter in 2019 with a focus on small and mid-capitalization public equities, particularly in the healthcare space. Mr. Natter has over a decade of successful public healthcare equity investing experience.\n<\/p>\n<p><b><span class=\"bwuline\">Certain Information Concerning the Participants<\/span><\/b><\/p>\n<p>\nKent Lake Partners LP (\u201cKent Lake Partners\u201d), together with the other Participants (as defined below), intends to file a preliminary proxy statement and an accompanying GOLD universal proxy card with the Securities and Exchange Commission (\u201cSEC\u201d) to be used to solicit votes for, among other matters, the election of its slate of highly-qualified director nominees at the 2025 annual meeting of stockholders of Quanterix Corporation, a Delaware corporation (the \u201cCompany\u201d).\n<\/p>\n<p>\nKENT LAKE STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING ITS GOLD PROXY CARD, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC\u2019S WEB SITE AT <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sec.gov%2F&amp;esheet=54224976&amp;newsitemid=20250317350313&amp;lan=en-US&amp;anchor=HTTP%3A%2F%2FWWW.SEC.GOV&amp;index=3&amp;md5=d8879d44dafefaece4cd61a1e1f4a2dc\">HTTP:\/\/WWW.SEC.GOV<\/a>. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS\u2019 PROXY SOLICITOR.\n<\/p>\n<p>\nThe participants in the proxy solicitation are currently anticipated to be Kent Lake Partners, Kent Lake PR LLC (\u201cKent Lake PR\u201d) and Benjamin Natter (collectively, the \u201cKent Lake Parties\u201d); and Alexander G. Dickinson, Bruce Felt and Hakan Sakul (the \u201cKent Lake Nominees\u201d and collectively with the Kent Lake Parties, the \u201cParticipants\u201d).\n<\/p>\n<p>\nAs of the date hereof, Kent Lake Partners directly beneficially owned 2,879,999 shares of the Company\u2019s Common Stock, $0.001 par value per share (the \u201cCommon Stock\u201d). Kent Lake PR, as the investment adviser and as the general partner to Kent Lake Partners, may be deemed to beneficially own the 2,879,999 shares of Common Stock beneficially owned by Kent Lake Partners. Mr. Natter, as the Managing Member of Kent Lake PR, may be deemed to beneficially own the 2,879,999 shares of Common Stock beneficially owned by Kent Lake Partners. None of the Kent Lake Nominees beneficially own any shares of Common Stock. All of the foregoing information is as of the date hereof unless otherwise disclosed.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250317350313\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250317350313\/en\/<\/a><\/span><\/p>\n<p><b>Investor<br \/>\n<br \/><\/b><br \/>Ben Natter, 415-237-0007<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:info@kentlakecap.com\">info@kentlakecap.com<br \/>\n<\/a><\/p>\n<p>Saratoga Proxy Consulting LLC<br \/>\n<br \/>John Ferguson \/ Ann Marie Mellone<br \/>\n<br \/>212-257-1311 \/ 888-368-0379<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:info@saratogaproxy.com\">info@saratogaproxy.com<br \/>\n<\/a><\/p>\n<p><b>Media<br \/>\n<br \/><\/b><br \/>Joe Germani \/ Kendall Heebink<br \/>\n<br \/>Longacre Square Partners<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:KentLake@longacresquarepartners.com\">KentLake@longacresquarepartners.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Latin America Caribbean Puerto Rico<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Banking Professional Services Finance<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call Believes Proposed Transaction with Akoya Significantly Undervalues Quanterix Encourages Shareholders to Vote Against Transaction to Protect Long-Term Value of their Investment RINCON, Puerto Rico&#8211;(BUSINESS WIRE)&#8211; Kent Lake PR LLC (\u201cKent Lake\u201d) is a holder of 7.47% of the outstanding common stock of Quanterix Corporation (\u201cQuanterix\u201d or the \u201cCompany\u201d) (NASDAQ: QTRX). Kent Lake has previously issued a public presentation detailing its opposition to the Company\u2019s proposed transaction (the \u201cTransaction\u201d) with Akoya Biosciences (\u201cAkoya\u201d) (NASDAQ: AKYA), and has also nominated three highly qualified, independent candidates for election to the Company\u2019s Board of Directors (the \u201cBoard\u201d). Kent Lake urges Quanterix management to address &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-826502","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call Believes Proposed Transaction with Akoya Significantly Undervalues Quanterix Encourages Shareholders to Vote Against Transaction to Protect Long-Term Value of their Investment RINCON, Puerto Rico&#8211;(BUSINESS WIRE)&#8211; Kent Lake PR LLC (\u201cKent Lake\u201d) is a holder of 7.47% of the outstanding common stock of Quanterix Corporation (\u201cQuanterix\u201d or the \u201cCompany\u201d) (NASDAQ: QTRX). Kent Lake has previously issued a public presentation detailing its opposition to the Company\u2019s proposed transaction (the \u201cTransaction\u201d) with Akoya Biosciences (\u201cAkoya\u201d) (NASDAQ: AKYA), and has also nominated three highly qualified, independent candidates for election to the Company\u2019s Board of Directors (the \u201cBoard\u201d). Kent Lake urges Quanterix management to address &hellip; Continue reading &quot;Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T20:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call\",\"datePublished\":\"2025-03-17T20:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/\"},\"wordCount\":947,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/\",\"name\":\"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-03-17T20:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/","og_locale":"en_US","og_type":"article","og_title":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk","og_description":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call Believes Proposed Transaction with Akoya Significantly Undervalues Quanterix Encourages Shareholders to Vote Against Transaction to Protect Long-Term Value of their Investment RINCON, Puerto Rico&#8211;(BUSINESS WIRE)&#8211; Kent Lake PR LLC (\u201cKent Lake\u201d) is a holder of 7.47% of the outstanding common stock of Quanterix Corporation (\u201cQuanterix\u201d or the \u201cCompany\u201d) (NASDAQ: QTRX). Kent Lake has previously issued a public presentation detailing its opposition to the Company\u2019s proposed transaction (the \u201cTransaction\u201d) with Akoya Biosciences (\u201cAkoya\u201d) (NASDAQ: AKYA), and has also nominated three highly qualified, independent candidates for election to the Company\u2019s Board of Directors (the \u201cBoard\u201d). Kent Lake urges Quanterix management to address &hellip; Continue reading \"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-17T20:03:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call","datePublished":"2025-03-17T20:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/"},"wordCount":947,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/","name":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-03-17T20:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250317350313r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kent-lake-urges-quanterix-management-to-address-key-questions-regarding-its-proposed-transaction-with-akoya-biosciences-during-todays-earnings-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today\u2019s Earnings Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=826502"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826502\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=826502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=826502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=826502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}